FSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder
March 23, 2023 at 19:21 PM EDT
Biotech company FSD Pharma Inc. (NASDAQ: HUGE)’s Australian business FSD Pharma Australia Pty Ltd. has been approved by the Alfred ...